What Is Hidden Behind Yellow Pixels: from Pathology to Intravascular Imaging of Atherosclerotic Plaque

Karlis Trusinskis1,2, Evija Knoka3,4, Laima Caunite3,4

  • 1Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia. karlistrusinskis@gmail.com.

Insights

This study compares intravascular ultrasound (iMAP-IVUS) and near-infrared spectroscopy (NIRS) for identifying vulnerable plaques. Findings aid in guiding treatment for atherosclerosis by assessing plaque lipid content.

Area of Science:

  • Cardiovascular Imaging
  • Atherosclerosis Research
  • Medical Technology Evaluation

Background:

  • Lipids play a critical role in atherosclerotic plaque progression and vulnerability.
  • Increased plaque vulnerability, independent of plaque burden, signifies atherosclerosis advancement.
  • Lipidic tissue assessment is vital for patient risk stratification and targeted therapies.

Purpose of the Study:

  • To review plaque pathology, lipid-lowering therapies, and intravascular imaging modalities.
  • To evaluate the correlation between iMAP-IVUS and NIRS in diagnosing vulnerable coronary plaques.
  • To clarify the comparability of different intracoronary imaging methods.

Main Methods:

  • Review of current literature on atherosclerotic plaque pathology and lipid-lowering therapies.
  • Utilization of intravascular ultrasound iMAP system (iMAP-IVUS) for imaging.
  • Application of near-infrared spectroscopy (NIRS) for imaging.
  • Comparative analysis of iMAP-IVUS and NIRS in identifying vulnerable plaques.

Main Results:

  • Lipids are essential in plaque evolution and vulnerability.
  • Vulnerable plaque parameters can be visualized by both iMAP-IVUS and NIRS.
  • Intravascular imaging systems exhibit varying sensitivities, specificities, and limitations.

Conclusions:

  • Lipid-lowering therapy is crucial for plaque stabilization.
  • Intravascular imaging systems offer valuable insights into vulnerable plaque characteristics.
  • Further research is needed to establish definitive comparability between iMAP-IVUS and NIRS.
Abstract